Absci Corporation (ABSI)
NASDAQ: ABSI
· Real-Time Price · USD
2.71
-0.11 (-3.90%)
At close: Jun 17, 2025, 3:59 PM
2.71
0.18%
After-hours: Jun 17, 2025, 07:59 PM EDT
-3.90% (1D)
| Bid | 2.04 |
| Market Cap | 345.05M |
| Revenue (ttm) | 3.64M |
| Net Income (ttm) | -107.48M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -2.91 |
| Forward PE | -4.04 |
| Analyst | Buy |
| Ask | 3.46 |
| Volume | 2,642,068 |
| Avg. Volume (20D) | 2,971,450 |
| Open | 2.82 |
| Previous Close | 2.82 |
| Day's Range | 2.70 - 2.87 |
| 52-Week Range | 2.01 - 6.33 |
| Beta | 2.07 |
About ABSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ABSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-1.69%
ABSI stock has given up its prior gain. Absci shar...
Unlock content with
Pro Subscription
1 month ago
-1.69%
Absci shares are trading higher after the company announced it began dosing the first participants in its Phase 1 ABS-101 clinical trial.
2 months ago · seekingalpha.com
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous MarketAbsci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Despite weak financials, Absci's internal pipeline, including ABS-101 and ABS-201, offe...
